NMO has been defined as a glialpathology as it affects AQP4 function in astrocytes, mainly of the optic nerve and spinal cord, the two tissues where AQP4 is highly expressed in the CNS 7. This evidence concerns the gene AQP4 and neuromyelitis optica.